MétaCan
Menu
Back to cohort
Record W4382983283 · doi:10.3390/curroncol30070465

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

2023· review· en· W4382983283 on OpenAlexaffvenueabout
Barbara Melosky, Natasha B. Leighl, David E. Dawe, Normand Blais, Paul F. Wheatley‐Price, Quincy S. Chu, Rosalyn A. Juergens, A. Sun, Devin Schellenberg, Diana N. Ionescu, Parneet Cheema

Bibliographic record

VenueCurrent Oncology · 2023
Typereview
Languageen
FieldMedicine
TopicLung Cancer Research Studies
Canadian institutionsWilliam Osler Health SystemUniversity of British ColumbiaSurrey Place CentreMcMaster UniversityUniversity of ManitobaJuravinski Cancer CentreUniversity of AlbertaUniversity of OttawaCentre Hospitalier de l’Université de MontréalUniversity Health NetworkCancerCare ManitobaOttawa HospitalPrincess Margaret Cancer CentreUniversity of Toronto
FundersJazz PharmaceuticalsF. Hoffmann-La RocheAstraZeneca
KeywordsMedicineConsensus conferenceIntensive care medicineRandomized controlled trialLung cancerStage (stratigraphy)MEDLINESystemic therapyNeuroendocrine tumorsRadiation therapyOncologyCancerPathologyInternal medicine

Abstract

fetched live from OpenAlex

Small-cell lung cancer (SCLC) is an aggressive, neuroendocrine tumour with high relapse rates, and significant morbidity and mortality. Apart from advances in radiation therapy, progress in the systemic treatment of SCLC had been stagnant for over three decades despite multiple attempts to develop alternative therapeutic options that could improve responses and survival. Recent promising developments in first-line and subsequent therapeutic approaches prompted a Canadian Expert Panel to convene to review evidence, discuss practice patterns, and reach a consensus on the treatment of extensive-stage SCLC (ES-SCLC). The literature search included guidelines, systematic reviews, and randomized controlled trials. Regular meetings were held from September 2022 to March 2023 to discuss the available evidence to propose and agree upon specific recommendations. The panel addressed biomarkers and histological features that distinguish SCLC from non-SCLC and other neuroendocrine tumours. Evidence for initial and subsequent systemic therapies was reviewed with consideration for patient performance status, comorbidities, and the involvement and function of other organs. The resulting consensus recommendations herein will help clarify evidence-based management of ES-SCLC in routine practice, help clinician decision-making, and facilitate the best patient outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.748
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.413
GPT teacher head0.550
Teacher spread0.137 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2023
Admission routes3
Has abstractyes

Explore more

Same venueCurrent OncologySame topicLung Cancer Research StudiesFrench-language works237,207